Australia markets open in 3 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
56.08-1.53 (-2.66%)
At close: 04:00PM EDT
55.40 -0.68 (-1.21%)
After hours: 06:44PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
460,652
507,364
214,310
-411
-5,607
Depreciation & amortisation
13,777
11,004
2,962
2,107
2,163
Deferred income taxes
-12,162
-7,840
-1,398
-21
36
Stock-based compensation
18,536
15,882
8,157
3,209
2,304
Change in working capital
-13,145
-2,676
-91,451
-915
-1,244
Accounts receivable
43,971
42,300
-178,480
-839
-1,970
Accounts payable
-3,840
-12,206
22,617
-329
102
Other working capital
466,097
514,733
104,118
4,198
-3,507
Other non-cash items
1,557
1,139
417
465
44
Net cash provided by operating activities
493,809
538,577
140,628
5,517
-675
Cash flows from investing activities
Investments in property, plant and equipment
-27,712
-23,844
-36,510
-1,319
-2,832
Acquisitions, net
-
-61,868
-2,591
-
-
Purchases of investments
-656,153
-730,490
-324,359
-52,077
-24,187
Sales/maturities of investments
416,300
269,591
37,014
24,350
27,969
Net cash used for investing activities
-329,369
-546,548
-326,438
-29,046
950
Cash flows from financing activities
Debt repayment
-467
-11
-
-
-
Common stock issued
41,688
89,475
246,190
28,758
-
Common stock repurchased
-
-
-62
-21
-
Other financing activities
-4,126
-4,145
-
-
-
Net cash used provided by (used for) financing activities
37,124
85,405
261,251
28,775
15
Net change in cash
201,608
77,468
75,461
5,229
246
Cash at beginning of period
151,461
87,426
11,965
6,736
6,490
Cash at end of period
353,025
164,894
87,426
11,965
6,736
Free cash flow
Operating cash flow
493,809
538,577
140,628
5,517
-675
Capital expenditure
-27,712
-23,844
-36,510
-1,319
-2,832
Free cash flow
466,097
514,733
104,118
4,198
-3,507